Practice question

Answer the question and get instant feedback.

ModerateInfectious DiseasesCDI-Recurrence Preventionus-abimus-usmle-step-2

A 59-year-old with recurrent CDI received fidaxomicin. To reduce recurrence, which adjunct may be considered in high-risk patients during antibiotic therapy?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.